Shinsuke Shimoyama MD, Presenter: Nothing to Disclose

Hisanobu Koyama MD, PhD, Abstract Co-Author: Nothing to Disclose

Yoshiharu Ohno MD, PhD, Abstract Co-Author: Research Grant, Toshiba Corporation Research Grant, Koninklijke Philips NV Research Grant, Bayer AG Research Grant, DAIICHI SANKYO Group Research Grant, Eisai Co, Ltd Research Grant, Terumo Corporation Research Grant, Fuji Yakuhin Co, Ltd Research Grant, FUJIFILM Holdings Corporation Research Grant, Guerbet SA

Shinichiro Seki, Abstract Co-Author: Nothing to Disclose

Mizuho Nishio MD, PhD, Abstract Co-Author: Research Grant, Toshiba Corporation

Kazuro Sugimura MD, PhD, Abstract Co-Author: Research Grant, Toshiba Corporation Research Grant, Koninklijke Philips NV Research Grant, Bayer AG Research Grant, Eisai Co, Ltd Research Grant, DAIICHI SANKYO Group

Adenocarcinoma is the most common histologic subtypes of lung cancer, and advances have taken place in oncology, molecular biology, pathology, radiology, and surgery during the past few decades. In 2011, an international multidisciplinary classification sponsored by the International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society (IASLC/ATS/ERS) was proposed. This new adenocarcinoma classification provides uniform terminology and diagnostic criteria for multidisciplinary strategic management. Therefore, the knowledge of radiological findings on not only CT, but also FDG-PET/CT and MRI according to this classification may be helpful for clinicians' more accurate classification or subtyping the nodules in routine clinical practice. The major teaching points of this exhibit are: 1. To learn IASLC/ATS/ERS classification of lung adenocarcinomas. 2. To determine the radiological features at various modalities including not only CT, but also PET/CT and MRI with corresponding pathologic findings in each subtype of adenocarcinoma based on IASLC/ATS/ERS Classification

1. IASLC/ATS/ERS classification of lung adenocarcinomas 2. Management of lung adenocarcinomas and the role of radiologists 3. Radiologic, such as CT, FDG-PET, and MRI, - pathologic correlation  

http://abstract.rsna.org/uploads/2014/14003571/14003571_nmh5.pdf

Shimoyama, S, Koyama, H, Ohno, Y, Seki, S, Nishio, M, Sugimura, K, CT, FDG-PET/ CT and MR Imaging of Lung Adenocarcinoma Corresponding to Newly Applied IASLC/ATS/ERS International Multidisciplinary Classification: Radiologic - Pathologic Correlation.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14003571.html